More interesting to us is whether Lp-PLA2 can directly or indirectly participate in the pathogenesis of cognitive impairment in PD by affecting key molecules associated with dementia, such as amyloid β or Tau, which requires further researches to reveal this issue. This evidence concerns the gene MAPT and Parkinson disease.